Authors







Mona D. Bostick, RDN, LDN

Latest:

Risks and Benefits of Disease-Modifying Therapies in People Aging With Multiple Sclerosis

More data are needed to ascertain the actual risks and benefits of DMT use, discontinuation, and de-escalation in older people with MS.




Lisa Gibbs, PhD

Latest:

Disaster Preparation for People With Multiple Sclerosis: A Scoping Review of Resources

Disaster events disproportionally affect persons with disabilities; as there is an increasing likelihood of disasters globally, clinicians should consider identifying resources to prepare patients for disasters.




Noemi Pasquarelli, PhD

Latest:

Wearing-Off Effect Reports in People With Multiple Sclerosis Receiving Ocrelizumab

Unsolicited reports of the wearing-off effect related to ocrelizumab were infrequent (< 2%).













Francine Buchanan, PhD

Latest:

Self-Management in Youth With Multiple Sclerosis During Transition to Adult Care and Adulthood: A Qualitative Study Using Interpretive Description

Youth-centered approaches are needed to support self-management-related concerns for youth with multiple sclerosis during the transition to adult care.




Lauren B. Strober, PhD

Latest:

Two Sides of the Same Coin: A Randomized Clinical Trial of the Unified Protocol for Addressing Depression and Anxiety in People With Multiple Sclerosis

Transdiagnostic interventions, such as the Unified Protocol, address both depression and anxiety and focus on the shared temperamental core of psychological disorders, which have been shown to impact functional outcomes as well.


Jiwon Oh, MD, PhD, FRCPC

Latest:

Self-Management in Youth With Multiple Sclerosis During Transition to Adult Care and Adulthood: A Qualitative Study Using Interpretive Description

Youth-centered approaches are needed to support self-management-related concerns for youth with multiple sclerosis during the transition to adult care.